Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Perazella

Showing results (121-130 of 278) with videos related to

Pageof 28
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 14, 2016
Cancer and Mortality in Solid-Organ Transplantation: Preventable or Inevitable?William S Asch, Mark A Perazella
Nature Clinical Practice. Nephrology|April 10, 2008
Early steroid treatment for drug-induced acute interstitial nephritisSteven G Coca, Mark A Perazella
Seminars in Dialysis|January 30, 2008
Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney diseaseMark A Perazella, Robert F Reilly
Seminars in Dialysis|August 20, 2011
Common clinical quandaries encountered in dialysis and ESRD: questions answeredMark A Perazella, Roger A Rodby
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2022
Drug-Induced Acute Kidney InjuryMark A Perazella, Mitchell H Rosner
Seminars in Dialysis|April 25, 2014
Common clinical quandaries encountered by nephrologists: more questions answeredRoger A Rodby, Mark A Perazella
Seminars in Dialysis|January 14, 2004
Intravenous iron and the risk of infection in end-stage renal disease patientsUrsula C Brewster, Mark A Perazella
The American Journal of Medicine|February 19, 2004
The renin-angiotensin-aldosterone system and the kidney: effects on kidney diseaseUrsula C Brewster, Mark A Perazella
The American Journal of Medicine|August 17, 2004
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failureBrian S Rifkin, Mark A Perazella
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2004
Drug-induced renal failure: a focus on tubulointerstitial diseaseGlen S Markowitz, Mark A Perazella
Pageof 28

Showing results (121-130 of 278) with videos related to

Sort By:
Pageof 28
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 14, 2016
Cancer and Mortality in Solid-Organ Transplantation: Preventable or Inevitable?William S Asch, Mark A Perazella
Nature Clinical Practice. Nephrology|April 10, 2008
Early steroid treatment for drug-induced acute interstitial nephritisSteven G Coca, Mark A Perazella
Seminars in Dialysis|January 30, 2008
Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney diseaseMark A Perazella, Robert F Reilly
Seminars in Dialysis|August 20, 2011
Common clinical quandaries encountered in dialysis and ESRD: questions answeredMark A Perazella, Roger A Rodby
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2022
Drug-Induced Acute Kidney InjuryMark A Perazella, Mitchell H Rosner
Seminars in Dialysis|April 25, 2014
Common clinical quandaries encountered by nephrologists: more questions answeredRoger A Rodby, Mark A Perazella
Seminars in Dialysis|January 14, 2004
Intravenous iron and the risk of infection in end-stage renal disease patientsUrsula C Brewster, Mark A Perazella
The American Journal of Medicine|February 19, 2004
The renin-angiotensin-aldosterone system and the kidney: effects on kidney diseaseUrsula C Brewster, Mark A Perazella
The American Journal of Medicine|August 17, 2004
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failureBrian S Rifkin, Mark A Perazella
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2004
Drug-induced renal failure: a focus on tubulointerstitial diseaseGlen S Markowitz, Mark A Perazella
Pageof 28